ClinicalTrials.gov
ClinicalTrials.gov Menu

Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01413113
Recruitment Status : Completed
First Posted : August 10, 2011
Last Update Posted : November 5, 2015
Sponsor:
Collaborators:
GlaxoSmithKline
National Cancer Institute (NCI)
National Comprehensive Cancer Network
Information provided by (Responsible Party):
University of Washington

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2013
  Actual Study Completion Date : October 2015